Skip to main content
. 2016 Dec 16;95(50):e5601. doi: 10.1097/MD.0000000000005601

Figure 2.

Figure 2

Forest plot of comparison for PFS (A) and PFSR (B) between EGFR-TKIs and taxanes in NSCLC. EGFR-TKI = epidermal growth factor receptor tyrosine kinase inhibitor, NSCLC = nonsmall-cell lung cancer, PFS = progression-free survival, PFSR = progression-free survival rate.